Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 72,147 Less Arrow 22,426 Less Arrow 87
Financial expenses 3,385 Less Arrow 905 More Arrow 5,677
Earnings before taxes -36,791 Less Arrow -50,198 More Arrow -43,452
EBITDA -36,756 Less Arrow -51,282 More Arrow -37,549
Total assets 175,496 Less Arrow 142,752 More Arrow 150,082
Current assets 126,902 Less Arrow 99,030 More Arrow 103,298
Current liabilities 29,225 Less Arrow 13,244 Less Arrow 10,522
Equity capital 68,857 More Arrow 98,591 More Arrow 120,597
- share capital 214 Less Arrow 205 Less Arrow 199
Employees (average) 86 Less Arrow 56 Less Arrow 23

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 39.2% More Arrow 69.1% More Arrow 80.4%
Turnover per employee 839 Less Arrow 400 Less Arrow 4
Profit as a percentage of turnover -51.0% Less Arrow -223.8% Less Arrow -49944.8%
Return on assets (ROA) -19.0% Less Arrow -34.5% More Arrow -25.2%
Current ratio 434.2% More Arrow 747.7% More Arrow 981.7%
Return on equity (ROE) -53.4% More Arrow -50.9% More Arrow -36.0%
Change turnover 51,538 Less Arrow 22,340 Less Arrow -18,327
Change turnover % 250% More Arrow 26141% Less Arrow -100%
Chg. No. of employees 30 More Arrow 33 Less Arrow 9
Chg. No. of employees % 54% More Arrow 143% Less Arrow 64%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.